Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis

Am J Hematol. 2019 Apr;94(4):E96-E99. doi: 10.1002/ajh.25408. Epub 2019 Jan 31.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Deferasirox / administration & dosage*
  • Deferasirox / adverse effects
  • Female
  • Ferritins / blood
  • Humans
  • Iron Chelating Agents / administration & dosage*
  • Iron Chelating Agents / adverse effects
  • Male
  • Medication Adherence*
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / drug therapy*
  • Patient Reported Outcome Measures*
  • Tablets
  • Thalassemia / blood
  • Thalassemia / drug therapy*

Substances

  • Iron Chelating Agents
  • Tablets
  • Ferritins
  • Deferasirox